Regenerative medicine projects to receive government funding

Fourteen research and development projects focused on regenerative medicines are to benefit from nearly £8.5m of government grant award funding.

Ten of the collaborative projects will address generic challenges in the development of cell-based therapies and will lead to demonstrators with commercial applicability.

Four projects will engage in the development of regenerative medicine therapeutics.

The investment in the projects, part of the Technology Strategy Board (TSB)-managed £21.5m Regenerative Medicine Programme, will see funding from the TSB, Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC).